N/A
N=1,612
Nudging Provider Adoption of Clinical Decision Support
Pulmonary Embolism
Bottom Line
View on ClinicalTrials.gov: NCT05203185 ↗Enrolled (actual)
1,612
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcome: Primary: Percentage of Patient Visits Where the Provider Adopted the Pulmonary Embolism Risk Kalculator (PERK) Tool — 39.11; 20.66 Percentage of Patient Visits
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Pulmonary Embolism Risk Kalculator (PERK) (Other)
- Age
- Adult, Older Adult · 25+ yrs
- Sex
- All
- Sponsor
- NYU Langone Health
- Primary completion
- Apr 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Patient Visits Where the Provider Adopted the Pulmonary Embolism Risk Kalculator (PERK) Tool |
39.11; 20.66 | — |
| SECONDARY Percentage of PE-Designated CTPA Tests That Are Positive for PE |
26.45; 10.76 | — |
Summary
The central hypothesis of this proposal is that the addition of a theory-informed "nudge" to a clinical decision support (CDS) tool will address identified behavioral barriers to use and significantly improve adoption by providers. Nudges are applications of behavioral science, defined as positive reinforcement and indirect suggestions that have a non-forced effect on decision making. This study will use a behavioral theory-informed process to develop a new CDS tool that includes a nudge that addresses barriers to adoption.
Eligibility Criteria
Inclusion Criteria
- Medical doctors, nurse practitioners and physician assistants working full time at Huntington Hospital and Long Island Jewish Valley Stream
Exclusion Criteria
- Does not meet the inclusion criteria
Data sourced from ClinicalTrials.gov (NCT05203185). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.